Ouiza Mesguida

Ouiza Mesguida

Auto-generated profile, based on publicly available information

Ouiza Mesguida

Universite de Pau et des Pays de l'Adour, CNRS, IPREM, Pau, France; GreenCell: Biopôle Clermont-Limagne, Saint Beauzire 63360, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
ABAmine Boukerb
Amine Boukerb
MCMelyssa Cambronel
Melyssa Cambronel
SRSophie Rodrigues
Sophie Rodrigues
OMOuiza Mesguida
Ouiza Mesguida
RKRikki Knowlton
Rikki Knowlton
NCNathalie Connil
Nathalie Connil
Prokaryotes and eukaryotes have coexisted for millions of years. The hormonal communication between microorganisms and their hosts, dubbed inter-kingdom signaling, is a recent field of research. Eukaryotic signals such as hormones, neurotransmitters or immune system molecules have been shown to modulate bacterial physiology. Among them, catecholamines hormones epinephrine/norepinephrine, released during stress and physical effort, or used therapeutically as inotropes have been described to affect bacterial behaviors (i.e., motility, biofilm formation, virulence) of various Gram-negative bacteria (e.g., Escherichia coli, Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa, Vibrio sp.). More recently, these molecules were also shown to influence the physiology of some Gram-positive bacteria like Enterococcus faecalis. In E. coli and S. enterica, the stress-associated mammalian hormones epinephrine and norepinephrine trigger a signaling cascade by interacting with the QseC histidine sensor kinase protein. No catecholamine sensors have been well described yet in other bacteria. This review aims to provide an up to date report on catecholamine sensors in eukaryotes and prokaryotes, their transport, and known effects on bacteria.

30 January 2025 in Microbiological Research
Verified
Journal Article
Open access
OMOuiza Mesguida
Ouiza Mesguida
SCStéphane Compant
Stéphane Compant
AWAdrian Wallner
Adrian Wallner
LALivio Antonielli
Livio Antonielli
RLRyszard Lobinski
Ryszard Lobinski
EAEléonore Attard
Eléonore Attard
Grapevine trunk diseases (GTDs), particularly Esca, represent a major challenge for viticulture worldwide, leading to substantial economic losses. With no effective control treatments available, developing new methods such as biocontrol is crucial for managing GTDs. Our aim was to select biocontrol bacteria effective against the white-rot fungal pathogen Fomitiporia mediterranea (Fmed) and to investigate their mechanisms of action. A stepwise screening of 58 bacterial strains was conducted in vitro to assess their ability to inhibit Fmed growth through volatile and diffusible metabolites production. The screening was also done on wood sawdust from seven different grapevine cultivars. Out of 58 tested strains, 49 inhibited Fmed growth by over 50 % through their volatile organic compounds, only eight achieving this through their agar-diffusible metabolites. Pseudomonas lactis SV9, Pseudomonas paracarnis S45, and Paenibacillus polymyxa SV13 exhibited a strong efficacy in inhibiting Fmed on wood sawdust in a cultivar-dependent manner. We selected these strains for whole genome analysis and metabolomic profiling via LC-MS/MS for diffusible compounds and SPME GC-MS for volatile compounds. P. polymyxa SV13 inhibited Fmed primarily through diffusible metabolites, producing mainly fusaricidin-type compounds. Conversely, Pseudomonas strains acted mainly via their volatile metabolites, producing mainly the antifungal compound dimethyl disulfide. Genome analysis of the three bacterial strains revealed gene clusters responsible for regulating both direct and indirect mechanisms in biocontrol agents (BCAs). Our findings highlight the importance of comprehensive studies that combine in vitro experiments mimicking field conditions, with detailed investigations into modes of action to improve BCAs efficacy.

26 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
AWAdrian Wallner
Adrian Wallner
Livio AntonielliLivio Antonielli
Livio Antonielli
OMOuiza Mesguida
Ouiza Mesguida
Patrice ReyPatrice Rey
Patrice Rey
Stephane CompantStephane Compant
Stephane Compant
Paenibacillus polymyxa is a bacterial species of high interest, as suggested by the increased number of publications on its functions in the past years. Accordingly, the number of described strains and sequenced genomes is also on the rise. While functional diversity was repeatedly suggested for this species, the available genomic data is now sufficient to confidently segregate strains affiliated to P. polymyxa into two major species groups. As these strains exhibit considerable potential in agriculture, medicine, and bioremediation, it is preferable to clarify their taxonomic affiliation to facilitate reliable and durable approval as active ingredients. Strains currently affiliated to P. polymyxa can be separated into two major species groups with differential potential in nitrogen fixation, plant interaction, secondary metabolism, and antimicrobial resistance, as inferred from genomic data.